Japan’s Nippon Shinyaku, Hong Kong’s Lee’s To Sell Ulcer Drug In China
This article was originally published in PharmAsia News
Executive Summary
Japan's Nippon Shinyaku and Hong Kong's Lee's Pharmaceutical Holdings have signed an agreement for marketing a gastritis and gastric ulcer drug in China